Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125925441 | 12592544 | 1 | I | 20160721 | 20160726 | 20160726 | EXP | PHHY2016IN099920 | NOVARTIS | GUPTA SK, ARORA P, MALLIK N, MITTAL R, SHARMA OD, KUMAR L. FLOW CYTOMETRY IN DIAGNOSIS OF MYELOMATOUS PLEURAL EFFUSION: A CASE REPORT. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION. 2016;32 (SUPPL 1):S138-S142 | 45.00 | YR | F | Y | 0.00000 | 20160726 | OT | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125925441 | 12592544 | 1 | PS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Unknown | UNK UNK, Q3MO | 21223 | ||||||||||
| 125925441 | 12592544 | 2 | SS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Unknown | UNK, QMO | 21223 | /month | |||||||||
| 125925441 | 12592544 | 3 | SS | THALIDOMIDE | THALIDOMIDE | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 125925441 | 12592544 | 4 | SS | THALIDOMIDE | THALIDOMIDE | 1 | Unknown | 50 MG, QD | 0 | 50 | MG | QD | |||||||
| 125925441 | 12592544 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 125925441 | 12592544 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 40 MG, QW (EVERY 28 DAYS) | 0 | 40 | MG | /wk | |||||||
| 125925441 | 12592544 | 7 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Unknown | 25 MG, (ON DAY 1-21) | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125925441 | 12592544 | 1 | Plasma cell myeloma |
| 125925441 | 12592544 | 3 | Plasma cell myeloma |
| 125925441 | 12592544 | 5 | Plasma cell myeloma |
| 125925441 | 12592544 | 7 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125925441 | 12592544 | OT |
| 125925441 | 12592544 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125925441 | 12592544 | Bone disorder | |
| 125925441 | 12592544 | Bone lesion | |
| 125925441 | 12592544 | Malignant neoplasm progression | |
| 125925441 | 12592544 | Osteolysis | |
| 125925441 | 12592544 | Pelvic mass | |
| 125925441 | 12592544 | Plasma cell myeloma | |
| 125925441 | 12592544 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |